Vir Biotechnology, Inc.

VIR

$9.41

Name : Vir Biotechnology, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $1,587,015,040.00

EPSttm : -3.13

Vir Biotechnology, Inc.

$9.41

2.39%

$0.22

VIR — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

12.23

Margin Of Safety %

Put/Call OI Ratio

0.45

EPS Next Q Diff

0.07

EPS Last/This Y

1.78

EPS This/Next Y

-0.9

Price

9.19

Target Price

20.56

Analyst Recom

1.1

Performance Q

23.69

Upside

-544.2%

Beta

1.67

Ticker: VIR

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-27	VIR	10.65	0.70	0.61	8573
2026-04-28	VIR	10.27	0.69	1.01	8857
2026-04-29	VIR	10.09	0.74	0.32	9433
2026-04-30	VIR	10.22	0.79	0.57	9522
2026-05-01	VIR	9.98	0.79	0.20	9607
2026-05-04	VIR	10.18	0.79	1.56	9609
2026-05-05	VIR	10.02	0.79	0.00	9624
2026-05-06	VIR	10.29	0.79	0.93	9658
2026-05-07	VIR	9.26	0.79	0.10	9717
2026-05-08	VIR	9.11	0.80	3.56	10553
2026-05-11	VIR	9.3	0.86	0.07	10954
2026-05-12	VIR	9.41	0.84	1.05	11154
2026-05-13	VIR	9.31	0.84	0.00	11151
2026-05-14	VIR	9.1	0.83	0.34	11140
2026-05-15	VIR	8.8	0.83	0.05	11606
2026-05-18	VIR	8.78	0.47	0.14	8829
2026-05-19	VIR	8.52	0.46	0.03	9238
2026-05-20	VIR	8.89	0.46	0.02	9271
2026-05-21	VIR	9.03	0.45	0.29	9365
2026-05-22	VIR	9.18	0.45	0.30	9402
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-27	VIR	10.65	154.7	-	-1.43
2026-04-28	VIR	10.27	154.7	-	-1.43
2026-04-30	VIR	10.22	154.7	-	-1.43
2026-05-01	VIR	9.98	154.7	-	-1.43
2026-05-04	VIR	10.17	154.7	-	-1.43
2026-05-05	VIR	10.02	154.7	-	-1.43
2026-05-06	VIR	10.28	154.7	-	-1.43
2026-05-07	VIR	9.27	154.7	-	-1.43
2026-05-08	VIR	9.12	25.8	-	-1.47
2026-05-11	VIR	9.30	25.8	-	-1.47
2026-05-12	VIR	9.40	25.8	-	-1.35
2026-05-13	VIR	9.32	211.9	-	-1.38
2026-05-14	VIR	9.10	211.9	-	-1.38
2026-05-15	VIR	8.80	204.9	-	-1.38
2026-05-18	VIR	8.78	204.9	-	-1.38
2026-05-19	VIR	8.52	204.9	-	-1.38
2026-05-20	VIR	8.89	204.9	-	-1.38
2026-05-21	VIR	9.04	204.9	-	-1.38
2026-05-22	VIR	9.19	204.9	-	-1.38
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-27	VIR	-2.86	3.92	14.61
2026-04-28	VIR	-2.86	3.92	14.61
2026-04-29	VIR	-2.60	3.92	14.48
2026-04-30	VIR	-2.60	3.92	14.48
2026-05-01	VIR	-2.55	3.92	14.48
2026-05-04	VIR	-2.55	3.23	14.48
2026-05-05	VIR	-2.54	3.23	14.48
2026-05-06	VIR	-2.54	3.23	14.48
2026-05-07	VIR	-2.54	3.23	14.48
2026-05-08	VIR	-2.54	3.23	14.48
2026-05-11	VIR	-2.43	3.48	13.84
2026-05-12	VIR	-2.43	3.48	13.27
2026-05-13	VIR	-2.43	3.48	13.27
2026-05-14	VIR	-2.43	3.48	13.22
2026-05-15	VIR	-2.45	3.48	13.22
2026-05-18	VIR	-2.45	3.55	12.69
2026-05-19	VIR	-2.73	3.55	12.69
2026-05-20	VIR	-2.73	3.55	12.69
2026-05-21	VIR	-2.73	3.55	12.23
2026-05-22	VIR	-3.07	3.55	12.23
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.85

Avg. EPS Est. Current Quarter

0.84

Avg. EPS Est. Next Quarter

-0.78

Insider Transactions

-3.07

Institutional Transactions

3.55

Beta

1.67

Average Sales Estimate Current Quarter

222

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

84.2

Max Drawdown 5-Year %

-92.2

Target Price

20.56

P/E

Forward P/E

PEG

P/S

23.66

P/B

1.82

P/Free Cash Flow

EPS

-3.14

Average EPS Est. Cur. Y

-1.38

EPS Next Y. (Est.)

-2.28

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-675.96

Relative Volume

0.34

Return on Equity vs Sector %

-81.5

Return on Equity vs Industry %

-65.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.04

EBIT Estimation

◆ VIR Healthcare

$9.19

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

23/25

Volume

11/15

Valuation

10/20

TP/AR

4/10

Options

8/10

RSI

46.3

Range 1M

25.6%

Sup Dist

4.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

12/30

Estimates

2/20

Inst/Vol

8/15

Options

7/10

EPS Yr

38.8%

EPS NY

-21.2%

52W%

66.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +123.7% upside

Quality

6/30

Valuation

16/30

Growth

9/25

Stability

8/10

LT Trend

3/5

Upside

+123.7%

Quality

Vir Biotechnology, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 367

Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. It has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

VIR

Latest News

—

Caricamento notizie per VIR…

stock quote shares VIR – Vir Biotechnology, Inc. Stock Price stock today

news today VIR – Vir Biotechnology, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch VIR – Vir Biotechnology, Inc. yahoo finance google finance

stock history VIR – Vir Biotechnology, Inc. invest stock market

stock prices VIR premarket after hours

ticker VIR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: VIR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y